Crossmark

A review of the effect of SGLT2 inhibitors on clinical and glycemic outcomes in hospitalized patients: data from studies that included patients with diabetes

Crossref DOI link: https://doi.org/10.1007/s42000-025-00702-x

Published Online: 2025-09-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ntelis, Spyridon

Singh, Lakshmi G.

Hernandez, Reynier

Spanakis, Elias K. https://orcid.org/0000-0002-9352-7172
License Information

Text and Data Mining valid from 2025-09-10

Version of Record valid from 2025-09-10
More Information

Article History

Received: 30 January 2025

Accepted: 21 July 2025

First Online: 10 September 2025

Declarations

:

: This is a review article. No ethical approval is required.

: Informed consent is not applicable.

: E.K.S. was partially supported by VA Merit Award 1I01CX001825 from the U.S. Department of Veterans Affairs Clinical Sciences Research and Development Service and has received unrestricted research support from Dexcom and Tandem Diabetes (to Baltimore VA Medical Center and the University of Maryland) for the conduct of clinical trials. No other potential conflicts of interest relevant to this article were reported.

Document is current

Any future updates will be listed below